Ureteral stents are small tubes inserted into the ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. Ureteral stents are flexible in nature and approximately 10 inches in length. The most common application of ureteral stents is the treatment of kidney stones. Other applications include stricture (abnormal narrowing of the ureter), and tumors pushing the ureter, leading to a blockage. Moreover, swollen, inflamed, or damaged ureteral tubes in need of healing can have a stent placed to keep the kidney draining during the healing process.
The global ureteral stents market size was valued at US$ 492.6 million in 2017 and is expected to witness a CAGR of 5.7% over the forecast period (2018 – 2026).
Increasing prevalence kidney related disorders is expected to drive the ureteral stents market revenue
Rising prevalence of urolithiasis worldwide owing to changes in lifestyle such as lack of physical activity and dietary habits is the major factor driving the ureteral stents market revenue. Urolithiasis is a common urologic problem and constitutes a significant burden on the health care system. According to the National Health and Nutrition Examination Survey (NHANES) 2003 report, the prevalence of urolithiasis has increased over the last three decades in the U.S. and projected to experience economic burden, with an additional value of US $1.24 billion per year by 2030.
Along with elderly and adult population, kidney stones also affect children of all ages. According to the Journal of Urology 2015 data, ureteral stent placement is the most common procedures performed in approximately 20% of children with stones. The weighted average annual cost of care for pediatric urolithiasis is US $220 million per year.
Urinary incontinence (UI) is also a significant health problem worldwide with increasing geriatric population rate. It has a large economic and social impact on individuals and nation. According to the European Urology 2012 report, the Epidemiology of Lower Urinary Tract Symptoms (EpiLUTS) reported relatively high UI prevalence rates of 13.3% for men and 30.3% for women in the United Kingdom, Sweden, and the U.S.
Ureteral Stents Market – Regional Insights
On the basis of region, the global ureteral stents market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America and Europe are expected to foresee significant growth in 2026 owing to increased number of urological surgeries, increasing prevalence of kidney stones and presence of major industry players. According to a European Urology study of 2012, in the U.S., kidney stone affects 1 in 11 people, and it is estimated that approximately 600,000 Americans suffer from urinary stones every year.
Asia Pacific ureteral stents market is expected to grow at highest CAGR due to increasing obesity and diabetes patient population prone to kidney disorders and developing healthcare infrastructure in the region. According to a research study published in Current Science journal 2005 data, in India, nearly 12% of patient had urinary stones and out of which 50% may end up with loss of kidney functions.
Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2172
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154